RedShiftBio™ is a provider of innovative analytical instrumentation for the research, development and manufacture of protein therapeutic drugs.
The company has developed a powerful new analytical technique, Microfluidic Modulation Spectroscopy, or MMS, that enables direct probing of the biophysical structure of proteins. The proprietary MMS technology provides the most comprehensive structural information across five key measurements, in a single automated analysis, replacing the requirement to run samples on multiple instruments.
Measurements can be easily performed with high sensitivity to “see change™” over a wide concentration range, from 0.1 mg/mL to over 200 mg/mL without dilution. This greatly simplifies workflow and analytical comparisons across every stage of development and manufacturing.